MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
Architects: PhotoBioModulation Therapy (PBMT)
LumiThera
Finance & Acquisition: LumiThera
Parents
LumiThera
Children
*The key investors in LumiThera PBMT technology include: WaterStar Capital, Imagine Ventures, Keiretsu Capital, Water Star Mercury Fund, Nikon Corporation, Celeste Management:
2020: LumiThera Collects $14M in Series C Round
2020: WaterStar Capital, an Atlanta-based institutional group, was the lead investor. Seattle-based Imagine Ventures, a participant in the company's Series B round further co-invested in the Series C round. Keiretsu Capital, Water Star Mercury Fund, Nikon Corporation and Celeste Management, a family-office, were also participants in the Series C round.
Celeste Management: Participated in Series C.
Imagine Ventures: Participated in both Series B and C.
Keiretsu Capital: Participated in Series C.
Leste Clearway and Serengeti Asset Management: Provided debt financing
Nikon Corporation: Participated in Series C.
RPR Venture: Participated in Series B.
WaterStar Capital: Lead investor in Series C.
WaterStone Capital: Participated in Series B.
Jumps
Key People: LumiThera
Organization & Developments: LumiThera